Sorrento Therapeutics (SRNE) Short Interest Ratio & Short Volume

Short interest is the volume of Sorrento Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 3,517,500 shares of SRNE short. Learn More on Sorrento Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SRNE shares currently have a short interest ratio of 13.0. Learn More on Sorrento Therapeutics's short interest ratio.

Sorrento Therapeutics saw a drop in short interest in May. As of May 15th, there was short interest totaling 3,517,500 shares, a drop of 0.7% from the previous total of 3,543,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Sorrento Therapeutics: Windtree Therapeutics, Inc. (14.26%), Processa Pharmaceuticals, Inc. (6.74%), Protagenic Therapeutics, Inc. (25.79%), Conduit Pharmaceuticals Inc. (7.18%), Qualigen Therapeutics, Inc. (5.09%), Scinai Immunotherapeutics Ltd. (0.12%), Spruce Biosciences, Inc. (0.04%), Evaxion Biotech A/S (1.07%), ZyVersa Therapeutics, Inc. (4.66%), GRI Bio, Inc. (2.78%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks.

Short selling SRNE is an investing strategy that aims to generate trading profit from Sorrento Therapeutics as its price is falling. SRNE shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Sorrento Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SRNE, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SRNE, twice per month. The most recent reporting period available is May, 15 2025.